Point72 Asset Management L.P. 13D and 13G filings for Merrimack Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:04 pm Sale |
2022-12-31 | 13G | Merrimack Pharmaceuticals, Inc. MACK |
Point72 Asset Management L.P. | 0 0.000% |
-900,981 (Position Closed) |
Filing |
| 2022-08-04 4:28 pm Purchase |
2022-08-03 | 13G | Merrimack Pharmaceuticals, Inc. MACK |
Point72 Asset Management L.P. | 900,981 6.700% |
900,981 (New Position) |
Filing |